Log In
BCIQ
Print this Print this
 

CPI-431-32

  Manage Alerts
Collapse Summary General Information
Company ContraVir Pharmaceuticals Inc.
DescriptionCyclophilin A (CYPA; PPIA) antagonist
Molecular Target Cyclophilin A (CYPA) (PPIA)
Mechanism of ActionCyclophilin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat HBV infection; Treat HCV/HBV/HIV-1 co-infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/13/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today